Literature DB >> 1449406

Cerebral glucose metabolism in Parkinson's disease with and without dementia.

R F Peppard1, W R Martin, G D Carr, E Grochowski, M Schulzer, M Guttman, P L McGeer, A G Phillips, J K Tsui, D B Calne.   

Abstract

Although cognitive impairment is commonly associated with Parkinson's disease, the relative importance of cortical and subcortical pathologic changes to the development of dementia is controversial. Characteristic abnormalities in cortical glucose metabolism have been reported previously in Alzheimer's disease, a disease in which cortical changes predominate. We measured cerebral glucose metabolism with positron emission tomography in 20 control subjects and in 14 patients with PD with mental status ranging from normal to severely demented to determine whether changes in cortical glucose metabolism occur in early PD and whether the degree and pattern of metabolic change relate to the severity of dementia. The patients were divided into demented and nondemented groups according to the results of neuropsychological assessment. Age-adjusted covariance analyses were performed, since the age distribution varied between groups. The nondemented patients with PD showed widespread cortical glucose hypometabolism without any selective temporoparietal defects. The pattern of glucose hypometabolism seen in the demented patients with PD resembled that described in patients with Alzheimer's disease; ie, there was a global decrease in glucose metabolism, with more severe abnormalities observed in the temporoparietal regions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449406     DOI: 10.1001/archneur.1992.00530360060019

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  32 in total

Review 1.  Neuroimaging and cognition in Parkinson's disease dementia.

Authors:  Lisa C Silbert; Jeffrey Kaye
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

2.  Simultaneous voltammetric detection of glucose and lactate fluctuations in rat striatum evoked by electrical stimulation of the midbrain.

Authors:  Alexandra G Forderhase; Hannah C Styers; Christie A Lee; Leslie A Sombers
Journal:  Anal Bioanal Chem       Date:  2020-07-14       Impact factor: 4.142

3.  Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.

Authors:  David Garcia-Garcia; Pedro Clavero; Carmen Gasca Salas; Isabel Lamet; Javier Arbizu; Rafael Gonzalez-Redondo; Jose A Obeso; Maria C Rodriguez-Oroz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-08       Impact factor: 9.236

4.  Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.

Authors:  Rafael González-Redondo; David García-García; Pedro Clavero; Carmen Gasca-Salas; Reyes García-Eulate; José L Zubieta; Javier Arbizu; José A Obeso; María C Rodríguez-Oroz
Journal:  Brain       Date:  2014-06-20       Impact factor: 13.501

5.  Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

Authors:  Liang-Jun Yan; Ming Xiao; Ran Chen; Zhiyou Cai
Journal:  Aging Neurodegener       Date:  2013-08

6.  Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing.

Authors:  Y Abe; T Kachi; T Kato; Y Arahata; T Yamada; Y Washimi; K Iwai; K Ito; N Yanagisawa; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

7.  Cognitive impairments in progression of Parkinson's disease.

Authors:  D A Stepkina; V V Zakharov; N N Yakhno
Journal:  Neurosci Behav Physiol       Date:  2010-01

8.  Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection.

Authors:  Shiek Ssj Ahmed; Winkins Santosh; Suresh Kumar; Hema T Thanka Christlet
Journal:  J Biomed Sci       Date:  2009-07-13       Impact factor: 8.410

Review 9.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 10.  Cellular metabolic and autophagic pathways: traffic control by redox signaling.

Authors:  Matthew Dodson; Victor Darley-Usmar; Jianhua Zhang
Journal:  Free Radic Biol Med       Date:  2013-05-20       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.